Clinical Trial Update: Efficacy and Safety Study of Ataciguat Versus Placebo in Patients With Neuropathic Pain [Phase 2]

View source ↗

Summary

Completed Phase 2 trial comparing ataciguat to placebo to assess efficacy and safety in patients with neuropathic pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Pain

Drugs mentioned

• Ataciguat (Ataciguat)

Snippet

Sponsor: Sanofi | Conditions: Pain | Phase 2 | Status: COMPLETED